Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.
Press releases published on June 10, 2025

Rx Bandz Wins Two Top Awards at BIONJ Conference
Company Wins Best Company Presentation and Most Inspiring Presentation DENVILLE, NJ, UNITED STATES, June 10, 2025 /EINPresswire.com/ -- Rx Bandz emerged as the competition standout at BioNJ’s 15th Annual BioPartnering Conference, taking home two of the …

Turning Uncertainty into Opportunity: VEXOS Opens Second Vietnam Office
HANOI, VIETNAM, June 10, 2025 /EINPresswire.com/ -- Vexos today announced the opening of its second office in Vietnam, located in Hanoi as part of its ongoing commitment to expand its Custom Material Solutions (CMS) business, and enhance global sourcing …

LinkShadow Unveils CyberMeshX Platform: Ushering in the Next Era of Cybersecurity
LinkShadow unveils its groundbreaking CyberMeshX Platform, transitioning from siloed security to a comprehensive, mesh-driven cybersecurity ecosystem. ATHENS, GA, UNITED STATES, June 10, 2025 /EINPresswire.com/ -- LinkShadow, a global leader in cutting- …

NuggMD Now Serves All Eligible Medical Cannabis Patients Nationwide via Secure Telehealth Platform
Los Angeles, June 10, 2025 (GLOBE NEWSWIRE) -- NuggMD, the nation’s leading medical marijuana telehealth platform, is proud to announce that it now provides secure access to medical cannabis evaluations in every state where telemedicine is legally …

Mochi Health Launches Enhanced Online Platform to Support Medical Weight Loss Patients Nationwide
SAN FRANCISCO, June 10, 2025 (GLOBE NEWSWIRE) -- Mochi Health, a physician-founded telehealth company delivering medical weight loss care directly to patients, announced today the launch of its newly upgraded online platform. The improvements are designed …

Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech
EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary …

Cooper Aerobics Partners with Parker University
DALLAS, June 10, 2025 (GLOBE NEWSWIRE) -- Cooper Wellness Strategies (CWS), a Cooper Aerobics company, announces a partnership with Parker University, bringing the medically validated CooperFit™ cardiovascular fitness test to two Parker University …

PlushCare Launches Enhanced Online Weight Loss Program to Expand National Access to GLP-1 Prescriptions Through Board-Certified Doctors
San Francisco, June 10, 2025 (GLOBE NEWSWIRE) -- PlushCare, a leading virtual healthcare platform, has announced a significant upgrade to its online Weight Loss Program, enabling greater access to GLP-1-based prescription treatments such as semaglutide …

Enhance.MD Launches Nationwide Telehealth Expansion to Support Men’s Hormonal Health and Medically Supervised Weight Loss
San Diego, June 10, 2025 (GLOBE NEWSWIRE) -- Enhance.MD, a U.S.-based telehealth provider specializing in men’s hormonal optimization and metabolic wellness, has officially expanded its clinical care services nationwide. This expansion supports a growing …

Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
Not for dissemination in the United States of America VANCOUVER, British Columbia, June 10, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that it is getting closer to filing its annual audited financial …

argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease
ALKIVIA data demonstrate significant improvement in muscle strength and physical function in myositis patients treated with efgartigimod RHO data show efgartigimod achieved sustained reduction in autoantibodies and improved functional outcomes in patients …

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus…
Consideration composed of a $350m up-front payment and up to $1.0bn in development, regulatory and commercial milestones, along with mid-single to low double-digit royalties on Global Net Sales OTELFINGEN, Switzerland, June 10, 2025 (GLOBE NEWSWIRE) -- …

ReflexMD Expands Digital Health Access Nationwide with Seamless Prescription Experience
Claymont, June 10, 2025 (GLOBE NEWSWIRE) -- ReflexMD, a telehealth platform redefining access to medical treatment for everyday health needs, today announced the nationwide availability of its streamlined online service designed to simplify how patients …

BioAegis Therapeutics Announces US Navy Contract to Support Phase 2 Study of Recombinant Human Gelsolin, for Inflammasome-Driven Decompression Sickness (DCS)
NORTH BRUNSWICK, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, a pioneering biotech company at the forefront of innovative therapies for acute and chronic inflammatory diseases, announces that it will conduct a Phase 2 study of rhu-pGSN …

Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial
SOUTH SAN FRANCISCO, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced it will …

myLAB Box Announces Official Website Update Featuring At-Home Wellness Testing Services
Los Angeles, June 10, 2025 (GLOBE NEWSWIRE) -- myLAB Box, a nationwide provider of at-home health screening solutions, has updated its official website to expand access to its broad catalog of wellness test kits. Now available across the United States, the …

Xilio Therapeutics Appoints Akintunde Bello, Ph.D., to its Board of Directors
WALTHAM, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced the …

Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 74 …

NetraMark Completes 2025 Annual General Meeting
TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence (AI) solutions company transforming clinical trial design in the pharmaceutical …

Daradia’s Web-Based MSK Ultrasound Simulator Pioneers a New Era in Pain Medicine Training Across Europe and Beyond
Cadaver-Free, Accessible Learning Empowers Physicians to Refine Ultrasound-Guided Skills KOLKATA, WEST BENGAL, INDIA, June 10, 2025 /EINPresswire.com/ -- In a bold step towards democratising medical education, Daradia: The Pain Clinic, a globally …